1. Home
  2. LX vs ORKA Comparison

LX vs ORKA Comparison

Compare LX & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LX
  • ORKA
  • Stock Information
  • Founded
  • LX 2013
  • ORKA 2004
  • Country
  • LX China
  • ORKA United States
  • Employees
  • LX N/A
  • ORKA N/A
  • Industry
  • LX Finance: Consumer Services
  • ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • LX Finance
  • ORKA Health Care
  • Exchange
  • LX Nasdaq
  • ORKA Nasdaq
  • Market Cap
  • LX 984.8M
  • ORKA 1.0B
  • IPO Year
  • LX 2017
  • ORKA N/A
  • Fundamental
  • Price
  • LX $6.55
  • ORKA $12.98
  • Analyst Decision
  • LX
  • ORKA Strong Buy
  • Analyst Count
  • LX 0
  • ORKA 6
  • Target Price
  • LX N/A
  • ORKA $43.60
  • AVG Volume (30 Days)
  • LX 2.6M
  • ORKA 413.1K
  • Earning Date
  • LX 03-19-2025
  • ORKA 02-15-2025
  • Dividend Yield
  • LX 2.11%
  • ORKA N/A
  • EPS Growth
  • LX N/A
  • ORKA N/A
  • EPS
  • LX 0.65
  • ORKA N/A
  • Revenue
  • LX $2,003,592,128.00
  • ORKA N/A
  • Revenue This Year
  • LX $10.73
  • ORKA N/A
  • Revenue Next Year
  • LX $5.17
  • ORKA N/A
  • P/E Ratio
  • LX $10.49
  • ORKA N/A
  • Revenue Growth
  • LX 11.56
  • ORKA N/A
  • 52 Week Low
  • LX $1.56
  • ORKA $12.24
  • 52 Week High
  • LX $6.83
  • ORKA $53.88
  • Technical
  • Relative Strength Index (RSI)
  • LX 64.51
  • ORKA N/A
  • Support Level
  • LX $5.58
  • ORKA N/A
  • Resistance Level
  • LX $6.83
  • ORKA N/A
  • Average True Range (ATR)
  • LX 0.31
  • ORKA 0.00
  • MACD
  • LX 0.01
  • ORKA 0.00
  • Stochastic Oscillator
  • LX 77.95
  • ORKA 0.00

About LX LexinFintech Holdings Ltd.

LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.

About ORKA Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

Share on Social Networks: